Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice

Cancer Immunology, Immunotherapy

Volumn 63, Issue 8, 2014, Pages 807-819

  Akeus, Paulina ^a   Langenes, Veronica ^a   Von Mentzer, Astrid ^a   Yrlid, Ulf ^a   Sjöling, Åsa ^a   Saksena, Pushpa ^b   Raghavan, Sukanya ^a   Quiding Järbrink, Marianne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anti tumor immunity; Chemokines; Colorectal cancer; Regulatory T cells; Tumor infiltrating lymphocytes

Indexed keywords

APC PROTEIN; CD4 ANTIGEN; CD69 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL25 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE DERIVED CHEMOKINE; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE POLYP; LAMINA PROPRIA; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ADENOMA; AGED; ANIMALS; CHEMOKINES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 84906790541     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-014-1555-6     Document Type: Article

References (54)

1. Weitz J, Moritz K, Jurgen D, Thomas H, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365:153-165. doi:10.1016/S0140-6736(05)17706-X (Pubitemid 40091806)
2. Schulmann K, Reiser M, Schmiegel W (2002) Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 16:91-114. doi:10.1053/bega.2002.0268
3. Choong MK, Tsafnat G (2012) Genetic and epigenetic biomarkers of colorectal cancer. Clin Gastroenterol Hepatol 10:9-15. doi:10.1016/j.cgh.2011. 04.020
4. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780. doi:10.1038/nrc1453
5. Fridman WH, Mlecnik B, Bindea G, Pagès F, Galon J (2011) Immunosurveillance in human non-viral cancers. Curr Opin Immunol 23:272-278. doi:10.1016/j.coi.2010.12.011
6. Mlecnik B, Sanchez-Cabo F, Charoentong P, Bindea G, Pagès F, Berger A, Galon J, Trajanoski Z (2010) Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction. BMC Genomics 11:S7. doi:10.1186/1471-2164-11-S1-S7
7. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pages F, Galon J (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 71:1263-1271. doi:10.1158/0008-5472.CAN-10-2907
8. Enarsson K, Lundin BS, Johnsson E, Brezicka T, Quiding-Järbrink M (2007) CD4+CD25 high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 37:282-291. doi:10.1002/eji.200636183 (Pubitemid 46128808)
9. Raghavan S, Quiding-Järbrink M (2011) Regulatory T cells in gastrointestinal tumors. Expert Rev Gastroenterol Hepatol 5:489-501. doi:10.1586/egh.11.44
10. Wing K, Sakaguchi S (2009) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11:7-13. doi:10.1038/ni.1818
11. Josefowicz SZ, Lu L-F, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531-564. doi:10.1146/annurev.immunol.25.022106.141623
12. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949. doi:10.1038/nm1093 (Pubitemid 39273735)
13. Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423-5434. doi:10.1158/1078-0432.CCR-06-0369 (Pubitemid 44497257)
14. Petersen RP, Campa MJ, Sperlazza J, Conlon D, Joshi M-B, Harpole DH, Patz EF (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107:2866-2872. doi:10.1002/cncr.22282 (Pubitemid 44937041)
15. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu Y-X, Wang F-S (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328-2339. doi:10.1053/j.gastro.2007. 03.102 (Pubitemid 46890865)
16. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L (2010) High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126:2635-2643. doi:10.1002/ijc.24989
17. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186-192. doi:10.1200/JCO.2008.18.7229
18. Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM, Halverson AL, Stryker SJ, Boller AM, Singal A, Sneed RK, Sarraj B, Ansari MJ, Oft M, Iwakura Y, Zhou L, Bonertz A, Beckhove P, Gounari F, Khazaie K (2012) Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 4:164ra159. doi:10.1126/scitranslmed.3004566
19. Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, Banham AH, Cerundolo V (2007) Increased frequency of regulatory T cells in peripheral blood and tumor infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7:7
20. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M-T, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet J-P, Sobhani I (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57:772-779. doi:10.1136/gut.2007.123794 (Pubitemid 351716970)
21. Michel S, Benner A, Tariverdian M, Wentzensen N, Hoefler P, Pommerencke T, Grabe N, von Knebel Doeberitz M, Kloor M (2008) High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99:1867-1873. doi:10.1038/sj.bjc.6604756
22. Svensson H, Olofsson V, Lundin S, Yakkala C, Björck S, Börjesson L, Gustavsson B, Quiding-Järbrink M (2012) Accumulation of CCR4+CTLA-4hi FOXP3+CD25hi regulatory T Cells in colon adenocarcinomas correlate to reduced activation of conventional T cells. PLoS One 7:e30695. doi:10.1371/journal.pone.0030695.t001
23. Whiteside TL (2013) Regulatory T cell subsets in human cancer: Are they regulating for or against tumor progression? Cancer Immunol Immunother 63:67-72. doi:10.1007/s00262-013-1490-y
24. Lan F, Zhang L, Wu J, Zhang J, Zhang S, Li K, Qi Y, Lin P (2011) IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma. Int J Colorectal Dis 26:1511-1518. doi:10.1007/s00384-011-1232-6
25. Fodde R, Smits R, Clevers H (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1:55-67. doi:10.1038/35094067 (Pubitemid 33741881)
26. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324
27. Staal FJT, Luis TC, Tiemessen MM (2008) WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 8:581-593. doi:10.1038/nri2360
28. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC, Pulendran B (2010) Activation of betacatenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329:849-853. doi:10.1126/science.1188510
29. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom-l, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell 75:631-639 (Pubitemid 23346362)
30. Westlund J, Livingston M, Fahlén-Yrlid L, Oldenborg P-A, Yrlid U (2012) CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance. Immunology 135:236-244. doi:10.1111/j.1365-2567.2011.03536.x
31. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
32. You S, Ohmori M, Peña MMO, Nassri B, Quiton J, Al-Assad ZA, Liu L, Wood PA, Berger SH, Liu Z, Wyatt MD, Price RL, Berger FG, Hrushesky WJM (2006) Developmental abnormalities in multiple proliferative tissues of ApcMin/+ mice. Int J Exp Pathol 87:227-236. doi:10.1111/j.1365-2613.2006.00477.x (Pubitemid 43781688)
33. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell ALM (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci 107:5540-5544. doi:10.1073/pnas.0912675107
34. Ishida T, Ueda R (2006) CCR4 as a novel molecular target for immunotheraphy of cancer. Cancer Sci 97:1139-1146. doi:10.1111/j.1349-7006.2006. 00307.x (Pubitemid 44430638)
35. Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, Wang H, Chen J, Wang H (2011) Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 6:e19495. doi:10.1371/journal.pone.0019495.s002
36. Wang C, Kang SG, Lee J, Sun Z, Kim CH (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2:173-183. doi:10.1038/mi.2008.84
37. Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180:122-129
38. Kunkel EJ, Cambell DJ, Butcher EC (2003) Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 10:313-323. doi:10.1038/sj.mn.7800196 (Pubitemid 39004258)
39. Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89:207-215. doi:10.1038/icb.2010.158
40. Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno EDT, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA (2012) The cytokines interleukin 27 and interferon-γ promote distinct treg cell populations required to limit infection-induced pathology. Immunity 37:511-523. doi:10.1016/j.immuni.2012.06.014
41. Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M (2012) CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res 72:4351-4360. doi:10.1158/0008-5472.CAN-12-0579
42. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, Khazaie K (2009) T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 69:5490-5497. doi:10.1158/0008-5472.CAN-09-0304
43. Staal FJT, Sen JM (2008) The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. Eur J Immunol 38:1788-1794. doi:10.1002/eji.200738118
44. Coletta PL (2004) Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 103:1050-1058
45. Muthuswamy RV, Sundström P, Börjesson L, Gustavsson B, Quiding-Järbrink M (2013) Impaired migration of IgA-secreting cells to colon adenocarcinomas. Cancer Immunol Immunother 62:989-997. doi:10.1007/s00262-013-1410-1
46. Dimberg J, Hugander A, Wågsäter D (2006) Protein expression of the chemokine, CCL28, in human colorectal cancer. Int J Oncol 28:315-319
47. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782-795. doi:10.1016/j.immuni.2013.10.003
48. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu G-Y, Österreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumor growth. Nature 491:254-258. doi:10.1038/nature11465
49. Erdman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG, Schauer DB (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 65:3998-4004. doi:10.1158/0008-5472.CAN-04-3104 (Pubitemid 40775635)
50. Lee SH, Hu L-L, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, Raz E (2010) ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 16:665-670. doi:10.1038/nm.2143
51. Ganesan AP, Johansson M, Ruffell B, Beltran A, Lau J, Jablons DM, Coussens LM (2013) Tumor-infiltrating regulatory t cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol 191:2009-2017. doi:10.4049/jimmunol.1301317
52. Hubert P, Jacobs N, Caberg J-H, Boniver J, Delvenne P (2007) The cross-talk between dendritic and regulatory T cells: Good or evil? J Leukoc Biol 82:781-794. doi:10.1189/jlb.1106694 (Pubitemid 47511037)
53. Wurbel M-A, McIntire MG, Dwyer P, Fiebiger E (2011) CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One 6:e16442. doi:10.1371/journal.pone.0016442.s008
54. Chen HJ, Edwards R, Tucci S, Bu P, Milsom J, Lee S, Edelmann W, Gümüs ZH, Shen X, Lipkin S (2012) Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J Clin Invest 122:3184-3196. doi:10.1172/JCI62110DS1